ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• The Stakeholder Benefits Of EHR eSource In Clinical Trials

  Discover the transformative power of EHR eSource integration through the eyes of a clinical research coordinator and project director in an adaptive platform trial.

• Opportunities For Enhancing Signal Detection In Schizophrenia Trials

  Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.

• Drive Innovation In Clinical Trial Software: 3 Trends You Need To Watch

  The clinical trial landscape is undergoing a transformative shift as technology increasingly shapes study design and execution. Explore three pivotal trends that are driving this evolution.

• Biosample Tracking: A Consenting Dilemma

  Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.

• One Day, Clinical Trials Will Represent The Real World

  What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.

• The Agentic AI Connectors That Matter In Clinical Development

  An inside look at the architecture behind agentic AI in clinical research, including how modular agents, connectors, and MCP frameworks enable scalable, interoperable automation across complex trial ecosystems. 

• Drive Superior Enrollment, Speed, And Quality Using eSource

  Explore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.

• Why Amendments Break Trials and How Elosity R3 Fixes It

  Protocol amendments are inevitable. The challenge is managing them without disrupting trial execution.

• Regulatory Opportunities For Decentralized Clinical Trials

  Project SHASTA, a pioneering effort to measure the benefits of decentralized trial elements, reveals significant regulatory opportunities that could shape the future of clinical research.

• Break The Contracting Bottleneck To Speed Site Activation

  With the appropriate training data, AI has the capability to automate information gathering, document creation, and workflow management.